A protocol for pre-treatment testing for antibodies to galactose-alpha-1,3-galactose to mitigate the risk of cetuximab hypersensitivity reactions – a retrospective cohort review
2025 · Cancer Treatment and Research Communications · 0 citations
https://doi.org/10.1016/j.ctarc.2025.100969